The research project, spawned by NIH efforts to create a “body-on-a-chip”, led to a lot of firsts, such as new 3D models for uterus and cervix, but it’s the applications that are generating the team’s excitement.
The Michigan researchers developed a microfluidic device that sandwiches a thin, permeable polyester membrane and a layer of cultured kidney cells between the top and bottom compartments.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
MicroMedicine, a new MGH spinout, is raising $35 million for its microfluidics technology. It's led by the founders of Verinata Health, which was acquired by Illumina in 2013 for $350 million.
Scientists are recognizing the power of transmogrifying cells to do their bidding. Heck, we recently found that heart cells can be reprogrammed into “pacemaker cells” through gene therapy. But it can still be a quandary to figure out an efficient way of inserting the necessary transformative materials into the cell. Cambridge startup SQZ Biotech has a slick, vector-free […]